Host Erik Torenberg talks to Jo Varshney, founder of VeriSIM Life, a Village portfolio company, and Eric Stefanich, director and senior scientist at Genentech.They explain how VeriSIM is changing drug discovery and development and why more and more drugs are being developed "in silico." They also discuss how startups can work in harmony with big companies and how big pharma has become much more forward-thinking than it is usually given credit for. Erik asks what opportunities they would be looking at if they were a VC in the space right now and how software-as-a-service (SaaS) in pharmaceuticals has evolved. They also discuss dealing with different types of investors when you're starting a biotech company. Thanks for listening — if you like what you hear, please review us on your favourite podcast platform. Check us out on the web at villageglobal.vc/podcast or get in touch with us on Twitter @villageglobal.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Trump $82 Million Bond Spree, Brazil Tariffs 'Too High,' More
16 Nov 2025
Bloomberg News Now
Ex-Fed Gov Resigned After Rules Violations, Trump Buys $82 Mil of Bonds, More
16 Nov 2025
Bloomberg News Now
THIS TRUMP INTERVIEW WAS INSANE!
16 Nov 2025
HasanAbi
Epstein Emails and Trump's Alleged Involvement
15 Nov 2025
Conspiracy Theories Exploring The Unseen
New Epstein Emails Directly Implicate Trump - H3 Show #211
15 Nov 2025
H3 Podcast
Trump Humiliates Himself on FOX as They Call Him Out
15 Nov 2025
IHIP News